Please enable JavaScript.
Coggle requires JavaScript to display documents.
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated…
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis
Introduction
-
-
-
TK inhibitors (BTKis)
currently in clinical use to treat patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)
-
Results
Elevated circulating and liver-infiltrated neutrophils in humans and mice with ALD correlate with increased bone marrow granulopoiesis
-
BTK abundance and phosphorylation are up-regulated in neutrophils and in the liver of clinical and preclinical AH
To evaluate the role of BTK in ALD, we performed unbiased RNA sequencing (RNA-seq) on circulating neutrophils from patients with AH and HCs
-